F. Kaltovich

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

J. Mascola, T. Pierson, C. Andrews, 2017, The Lancet.

Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

J. Mascola, D. Baltimore, E. Boritz, 2022, Nature Medicine.

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial.

J. Mascola, A. Namboodiri, R. Koup, 2019, The lancet. HIV.

Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.

D. Goldenberg, R. Sharkey, F. Kaltovich, 1988, Cancer research.

Radioimmunotherapy of Human Colonie Cancer Xenografts with 90 Y-labeled Monoclonal Antibodies to Carcinoembryonic Antigen 1

D. Goldenberg, R. Sharkey, F. Kaltovich, 2006 .

Delineation of a transplanted malignant melanoma with indium-111-labeled porphyrin.

C. Ljungquist, F. Kaltovich, N. Foster, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pulmonary accumulation of neutral diamine dithiol complexes of technetium-99m.

H. Wagner, U. Scheffel, K. Baidoo, 1994, Journal of pharmaceutical sciences.

Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.

J. Mascola, C. Andrews, J. Ledgerwood, 2022, The Lancet. Infectious diseases.

An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

J. Mascola, R. Koup, R. Bailer, 2017, npj Vaccines.

Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.

J. Mascola, T. Pierson, R. Koup, 2020, JAMA.